Exisulind Prior to Radical Prostatectomy

Summary

This trial will compare no treatment to exisulind therapy. Patients enrolled on the treatment arm will begin treatment 4 weeks prior to the scheduled date of surgical removal of the prostate and will take 375 mg by mouth daily for the 4 weeks prior to radical prostatectomy. Participants will be followed for total of 2 months from the time of starting study drug.

Timeline

Start

2002-04

Primary completion

2007-10

Completion

2007-10

Drugs

Indications